title: Tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent.
abstract: METHODS
  The objective of this case report is to report the development of tardive dyskinesia in an African-American adolescent male after short-term treatment with metoclopramide 10 mg orally three times daily secondary to delayed gastric emptying. The patient developed symptoms of tardive dyskinesia after 2 days of therapy with metoclopramide. Metoclopramide was discontinued and diphenhydramine 50 mg was initially administered intravenously followed with 25 mg orally every 4 hours as needed. While there are case reports of drug-induced tardive dyskinesia after intravenous administration of metoclopramide, this is to our knowledge the first report of tardive dyskinesia after short-term treatment with oral metoclopramide in an adolescent.
  
  
  CONCLUSIONS
  Awareness of the risk of development of this adverse effect even with short-term treatment with metoclopramide and in younger patients is important.
authors.affiliation: Department of Clinical Pharmacy, University of Tennessee Health Science Center, 881 Madison Ave, Suite 340, Memphis, TN 38163, USA.
authors.forename: Maryam
authors.initials: M
authors.lastname: Karimi Khaledi
authors.forename: Katie J
authors.initials: KJ
authors.lastname: Suda
authors.forename: Chasity M
authors.initials: CM
authors.lastname: Shelton
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000367:Age Factors; D000932:Antiemetics / Q000008:administration & dosage / Q000009:adverse effects*; D004155:Diphenhydramine / Q000008:administration & dosage; D004334:Drug Administration Schedule; D057915:Drug Substitution; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000008:administration & dosage / Q000009:adverse effects*; D009069:Movement Disorders / Q000209:etiology*; D012307:Risk Factors; D013997:Time Factors
chemical_list: D000932:Antiemetics; D004155:Diphenhydramine; D008787:Metoclopramide